Literature DB >> 21056699

Inflammatory responses in the atria: should they stay or should they go?

Heather S Duffy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056699      PMCID: PMC3058228          DOI: 10.1016/j.hrthm.2010.11.006

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  21 in total

Review 1.  The glitazones: proceed with caution.

Authors:  D Krische
Journal:  West J Med       Date:  2000-07

2.  Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).

Authors:  Kamakshi Lakshminarayan; Craig A Solid; Allan J Collins; David C Anderson; Charles A Herzog
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

Review 3.  PPARgamma and atherosclerosis: effects on cell growth and movement.

Authors:  W A Hsueh; R E Law
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

Review 4.  Thiazolidinediones--the new insulin enhancers.

Authors:  R J Jha
Journal:  Clin Exp Hypertens       Date:  1999 Jan-Feb       Impact factor: 1.749

Review 5.  Pioglitazone.

Authors:  P S Gillies; C J Dunn
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

6.  The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

Authors:  M Ricote; A C Li; T M Willson; C J Kelly; C K Glass
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

Review 7.  The role of glial reaction and inflammation in Parkinson's disease.

Authors:  E C Hirsch; T Breidert; E Rousselet; S Hunot; A Hartmann; P P Michel
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

Review 8.  Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.

Authors:  Pit Sertznig; Markus Seifert; Wolfgang Tilgen; Jörg Reichrath
Journal:  Am J Clin Dermatol       Date:  2008       Impact factor: 7.403

9.  Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.

Authors:  Brett Burstein; Xiao-Yan Qi; Yung-Hsin Yeh; Angelino Calderone; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2007-07-25       Impact factor: 10.787

Review 10.  Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?

Authors:  Harrihar A Pershadsingh
Journal:  Expert Opin Investig Drugs       Date:  2004-03       Impact factor: 6.206

View more
  1 in total

Review 1.  Role of connexins and pannexins in cardiovascular physiology.

Authors:  Merlijn J Meens; Brenda R Kwak; Heather S Duffy
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.